amgen glp-1 obesity drug market potential 2025 Anti-Obesity Outlook 2025–2032: Strong CAGR of 18.01% with USD 82.55 Billion Valuation Anti-Obesity Drugs Market Size &
Description
Overview of Diabetes Treatment [3]
Hung, S
Moreover, although GLP-1 has a significant effect on blood glucose control, its effect on lipid metabolism is relatively weak
The introduction of GLP-1 agonists and SGLT-2 inhibitors offers a promising therapeutic option
Supplementary Materials Data Availability Statement The data sets analysed during the current study are available from the corresponding author upon reasonable request.
